FTC poised to block Amgen's $27.8B deal for Horizon Therapeutics

The FTC is preparing to block Amgen's acquisition of Horizon Therapeutics, marking a new effort by antitrust enforcers to prevent a merger of pharmaceutical companies.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...